The MS Register in the U.K. is a database of over 16,000 pwMS and their recent study has shown fatigue symptoms reduced through diet.
Recent news about bexarotene inspires mixed feelings.
Paper looks at diet quality and the risk of further relapse after someone’s first demyelinating event, comparing three dietary patterns.
News articles in recent weeks have talked about repurposed drugs being used to treat COVID-19 patients including drugs used for MS. We...
A new study has been published looking into MS and propionic acid with some interesting results.
New research from a team of researchers from McGill University, Canada, have made a link between reducing the amount of methionine (an amino...
As research continues into myelin regeneration treatments, which could theoretically slow, prevent or even reverse the progression of MS...
A new randomised control trial has been published evaluating the effects of the combination of omega-3 and vitamin D supplements on a number...
Dr Jonathan White explains the results of two separate studies which looked at treatment of people over the age of 53.
At OMS, we believe that the evidence behind the recommendations of the 7 steps is extremely robust. In the 20 years since Professor Jelinek...
Ocrelizumab is an intravenous treatment which has only been offered to people with relapsing remitting MS (RRMS)...
Ibudilast is commonly prescribed in Japan for the treatment of asthma and stroke, and is currently being...
Dr Jonathan White explains the results of a 10 year prospective study into disease modifying drugs treatments for...
Investigators at Imperial College London demonstrated a link between certain blood lipid levels and increased...
A study appears to have found a link between multiple sclerosis and lower blood levels of vitamin K2, a fat-soluble molecule. VK2 ordinarily...
New research has found that existing guidelines on recommended vitamin D intake may be dangerously low.
A new treatment called Ocrelizumab has been found to have a positive effect on RRMS, but the nature of the market could mean it stays an...
A new study has found evidence that smoking negatively impacts people with relapsing-remitting multiple sclerosis...
New research shows that there is no association between the risk of later development of multiple sclerosis and...
A new meta analysis has shown that disease-modifying drugs for people with MS become less effective with age and for those older than 53...
Research from the University of Pennsylvania has concluded that there is a high incidence of poor ability to identify taste by PwMS...
Modifying risk factors like a poor diet, lack of exercise, smoking, lack of sun exposure is likely to make a big impact in slowing the...
The sixth paper in the HOLISM series has been published in the journal Behavioural Neurology. Meditation appears to be a valuable part of...
Can it really be that doctors know little about nutrition and are behind the times when it comes to multiple sclerosis research?
End of content
No more pages to load